Pathology Lectures

Intimal Thickening A Stereotyped Injury Response to Vascular Injury

65 slides · PPTX & PDF available

Download PDF
Request PowerPoint

PowerPoint animations are preserved in the original file.

Marks are temporary. Tap a drawing tool again to stop.
Slide index (65)
  1. Loading slide titles…

Loading presentation…

Swipe on touchscreens · Use ← / → to change slides, Home / End to jump.

Lecture topics

Slide index & full transcript (65 slides)

Text from the original slides, in presentation order. Diagrams and images remain in the viewer above.

Slide 1 · Intimal thickening: a stereotyped response to vascular injury

Endothelium, smooth muscle, matrix and luminal stenosis

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · What this lecture explains

Localize the intimal response within vascular wall architecture

Trace endothelial injury to smooth muscle recruitment and matrix synthesis

Explain why a reparative response can compromise flow

Recognize the shared mechanism in several clinically distinct vascular lesions

Slide 3 · The central injury–repair paradox

Endothelial injury or dysfunction

Smooth muscle recruitment and growth

Extracellular matrix accumulation

Neointimal narrowing

Repair restores wall coverage, but may reduce downstream perfusion.

Conceptual sequence — schematic

Slide 4 · Three concentric compartments frame the response

Intima: Endothelial-lined inner surface

Media: Smooth muscle-rich contractile layer

Adventitia: External supporting tissue

Slide 5 · The intima and media have different tasks

Intima

Interfaces directly with flowing blood

Maintains a selective barrier

Controls coagulation, inflammation and cell growth

Media

Contains most vascular smooth muscle cells

Adjusts vessel tone and caliber

Supplies cells capable of injury-associated remodeling

Slide 6 · The intima is the site of neointimal accumulation

Neointima is newly accumulated tissue in the intimal layer.

It contains smooth muscle cells together with extracellular matrix.

Its expansion projects toward the lumen rather than outward alone.

Distinguish the layer affected from the cell layer supplying much of the response.

Slide 7 · Two broad forms of vascular damage

Luminal narrowing

May develop progressively

Impairs delivery of blood to downstream tissues

Neointimal growth is one structural mechanism

Wall weakening

Can produce dilation or rupture

Represents a different dominant structural consequence

Must not be confused with intimal expansion

Slide 8 · Endothelial cells are active regulators

Endothelial cells (ECs) form a specialized single-cell lining.

They regulate permeability, hemostasis, vessel tone and inflammation.

They influence neighboring smooth muscle cell (SMC) growth.

Endothelium is not merely a passive nonporous lining.

Slide 9 · Basal endothelium protects circulating blood

Homeostatic barrier

Restricts inappropriate passage across vessel wall

Supports tissue-specific exchange

Maintains a nonadhesive blood-contacting surface

Protective mediators

Prostacyclin and thrombomodulin

Heparin-like molecules and plasminogen activator

Together support nonthrombotic conditions

Slide 10 · Endothelial antithrombotic products matter

Prostacyclin is among the endothelial antithrombotic mediators.

Thrombomodulin and heparin-like molecules regulate coagulation.

Plasminogen activator contributes to fibrinolytic capacity.

The same endothelial surface can adopt a prothrombotic phenotype after activation.

Slide 11 · Endothelial cells regulate vascular tone

Vasodilating signals

Nitric oxide (NO)

Prostacyclin

Favor smooth muscle relaxation

Vasoconstricting signals

Endothelin

Angiotensin-converting enzyme activity

Favor contraction via vascular signaling

Slide 12 · Endothelium recruits or restrains leukocytes

Activation can increase expression of adhesion molecules.

Cytokines and chemokines regulate leukocyte recruitment.

Inflammation can therefore amplify a local vascular response.

Adhesion and inflammatory signaling are components of endothelial phenotype.

Slide 13 · Endothelial products influence cell growth

Endothelium participates in remodeling decisions.

Growth-promoting examples

Platelet-derived growth factor (PDGF), fibroblast growth factor (FGF), colony-stimulating factors

Growth-inhibitory examples

Heparin-like mediators and transforming growth factor-β (TGF-β), functional table

Net result

Local growth depends on stimulus, cell state and the balance of mediators

Slide 14 · Endothelial function varies by vascular bed

Specialized permeability

Fenestrations facilitate exchange in sites such as glomeruli

Endothelium is adapted to local tissue requirements

Barrier specialization

CNS endothelium forms a restrictive barrier

Associated perivascular cells contribute

A single endothelial response cannot be assumed identical at all sites

Slide 15 · An activated endothelium changes its output

Hemodynamic or chemical stimulus

Endothelial activation

Adhesion, coagulation and inflammatory signals

Smooth muscle effects

Endothelial activation is a shift in function, not necessarily physical removal of cells.

Conceptual sequence — schematic

Slide 16 · Hemodynamic inputs can disturb endothelial state

Basal setting

Normal pressure and laminar flow support homeostatic function.

Altered forces

Abnormal shear patterns and stasis are activation-associated conditions.

Local consequences

EC expression of vasoactive and growth-regulatory products changes.

Do not interpret every change in flow as endothelial denudation.

Slide 17 · Biochemical and inflammatory activation inputs

Inflammatory

Proinflammatory mediators and microbial products can activate ECs.

Metabolic / toxic

Advanced glycation end products and tobacco products are among stimuli.

Other stresses

Hypoxia, acidosis, viruses and complement components also activate ECs.

Multiple distinct injuries converge on a smaller set of endothelial responses.

Slide 18 · Endothelial responses differ in timing

Rapid functional change

Can occur within minutes

Some changes require no new protein synthesis

Example: Transient junctional opening

Transcription-dependent change

Requires altered gene expression

New adhesion or signaling proteins may be produced

May develop over hours to days

Slide 19 · The activated endothelial program

Different stimuli emphasize different parts of this program.

Inflammatory

Adhesion molecules, cytokines and chemokines

Coagulation

Increased procoagulant or altered anticoagulant expression

Vascular reactivity

Altered NO and vasoconstrictor signaling

Remodeling

Growth factors and matrix-related signaling

Slide 20 · Dysfunction and denudation are not synonyms

Dysfunction

Endothelial layer may remain physically present

Phenotype becomes proinflammatory or prothrombotic

Cell signaling shifts

Denudation

Portion of endothelial lining is lost

Coverage needs to be restored

Adjacent ECs or circulating precursors may participate

Slide 21 · Medial smooth muscle cells are normally contractile

Vascular SMCs predominate in the tunica media.

In their basal state, they are largely nonproliferative.

They mediate constriction and relaxation in response to stimuli.

Baseline contractility does not eliminate their capacity to remodel.

Slide 22 · Smooth muscle cells can become biosynthetic

SMCs can proliferate following appropriate stimulation.

They are capable of synthesizing collagen, elastin and proteoglycans.

They may also elaborate growth factors and cytokines.

This plasticity allows wall repair but also intimal lesion formation.

Slide 23 · SMC phenotype: Normal versus neointimal

Cell proliferation

Basal medial SMCs: Low | Neointimal SMCs: Increased

Matrix biosynthesis

Basal medial SMCs: Lower | Neointimal SMCs: Increased

Contractile function

Basal medial SMCs: Prominent | Neointimal SMCs: Reduced

Primary context

Vascular tone | Injury-associated repair and remodeling

Slide 24 · Phenotypic switching enables vascular repair

Contractile medial SMC

Exposure to injury-related signals

Proliferative, biosynthetic state

Migration and intimal matrix production

The switch is a change in functional program, not a new cell lineage.

Conceptual sequence — schematic

Slide 25 · Extracellular matrix is part of the lesion

Neointima is not an accumulation of cells alone.

SMC-derived matrix contributes substantially to new tissue volume.

Collagen, elastin and proteoglycans are within SMC synthetic capabilities.

An apparently “cellular” repair reaction also creates a structural matrix scaffold.

Slide 26 · The process begins with endothelial injury

EC dysfunction or loss

Release / action of mediators

SMC recruitment and proliferation

ECM synthesis and intimal thickening

The source describes a convergent response rather than one disease-specific trigger.

Conceptual sequence — schematic

Slide 27 · Endothelial repair proceeds alongside wall remodeling

Endothelial coverage can be restored over injured areas.

The restored surface may re-establish more normal EC functions.

Repair of the lining and growth of the intimal layer are related but distinct events.

A repaired surface can coexist with a thicker intima.

Slide 28 · Where do replacement endothelial cells come from?

Adjacent lining

ECs migrate from nearby intact endothelium into denuded zones.

Circulation

Circulating endothelial precursors can contribute.

Result

Re-endothelialization helps restore the luminal barrier.

More than one possible source; It does not quantify their contributions.

Slide 29 · Migration of medial SMCs changes the wall boundary

SMCs reside in media

Injury-associated stimulation

SMCs enter the intimal compartment

New intimal cell population

A key spatial event is relocation into the layer adjacent to the lumen.

Conceptual sequence — schematic

Slide 30 · Two sources may populate neointima

Local medial SMCs

Already reside within the vessel wall

Can migrate toward the luminal compartment

Then proliferate and produce matrix

Circulating precursors

Circulating smooth muscle precursors are also described

Can contribute to the growing intimal population

Relative contribution is not specified in this excerpt

Slide 31 · Migration and proliferation are separate steps

SMC recruitment

SMC movement into intima

Expansion of intimal SMC population

Increased cell component of neointima

Recruitment changes location; Proliferation increases the number of cells.

Conceptual sequence — schematic

Slide 32 · Matrix synthesis consolidates the neointima

SMC biosynthetic activation

Collagen / matrix production

Cell-and-matrix intimal expansion

Potential reduction in luminal caliber

Matrix deposition is a structural consequence of the activated SMC phenotype.

Conceptual sequence — schematic

Slide 33 · Neointima contains both SMCs and matrix

Injury-associated smooth muscle cell accumulation

Extracellular matrix between and around cells

Expansion of intima toward vascular lumen

Slide 34 · The artery remodels through recognizable stages

Intact endothelium

EC dysfunction / loss

SMC migration + matrix

Neointimal expansion

Idealized sequence. The drawing does not specify lesion size, timing or lesion symmetry.

Slide 35 · Early and established neointima are conceptually different

Active expansion

SMCs are recruited and proliferate

ECM synthesis is increased

Endothelial repair may still be underway

More stable lesion

Endothelium may normalize

Neointimal SMCs can become nonproliferative

Accumulated cells / matrix can remain as thickened intima

Slide 36 · Platelets contribute injury-related stimuli

At the damaged interface

Platelets are identified as sources of relevant cytokines and growth factors.

Effect on SMCs

These mediators can promote the injury-associated phenotype.

Role in network

Platelet-derived signals act alongside EC and macrophage products.

Platelets as one of several signaling sources, not a sole initiator.

Slide 37 · Activated endothelial cells also signal to SMCs

Local sensor

Endothelium responds to shear and biochemical stresses.

Signal output

Growth-regulatory cytokines and mediators can change.

Downstream effect

Nearby SMC behavior is influenced within the same wall.

Endothelial function links the blood-facing environment with medial responses.

Slide 38 · Macrophages supply a second inflammatory input

Inflammatory response

Activated endothelium can facilitate inflammatory-cell trafficking.

Mediator source

Macrophage-derived cytokines and growth factors can stimulate SMC phenotypic change.

Interaction

The inflammatory response and vessel remodeling are connected.

Do not equate macrophage participation with proof of an atheromatous lipid core.

Slide 39 · Thrombin and complement extend the signal network

Thrombin

Identified as a stimulus for SMC phenotypic switching

Connects coagulation-related signaling with remodeling

Activated complement

Also implicated as a stimulus

Adds an immune-effector contribution to the response

Slide 40 · Signals converge on smooth muscle plasticity

Platelets

Endothelial cells

Macrophages

Thrombin

Activated complement

SMC phenotypic change

Signals include cytokines, growth factors, thrombin and activated complement.

Slide 41 · Cell proliferation plus matrix produces stenosis

New intimal SMCs

Extracellular matrix accumulation

Expansion of intimal tissue

Luminal encroachment

The combination—not either process alone—defines neointimal tissue accumulation.

Conceptual sequence — schematic

Slide 42 · The vascular response resembles ordinary wound healing

In an injured tissue

Resident cells respond to damage

Repair cells proliferate

Fibroblast-associated matrix helps fill the defect

In an injured artery

SMCs enter and populate the intima

These cells produce extracellular matrix

Tissue replacement can compromise a vascular lumen

Slide 43 · Why reparative intimal thickening can be harmful

Tissue growth inside a constrained vascular lumen reduces available space.

Narrowed vessels may deliver less blood to downstream tissues.

An initially protective healing program can therefore produce stenosis.

The biological purpose of repair is not identical to its hemodynamic outcome.

Slide 44 · Normalization can terminate active SMC growth

Endothelial restoration / normalization

Shift in local signaling context

Neointimal SMCs become nonproliferative

More stable intimal lesion

The source allows this transition; It does not imply all stenosis reverses.

Conceptual sequence — schematic

Slide 45 · Phenotypic quieting is not anatomical reversal

Cellular activity

SMCs may stop proliferating

Biosynthetic drive can fall

Endothelial phenotype may return toward basal state

Residual structure

SMCs and ECM have accumulated in the intima

The narrowed lumen may persist

Repair and lumen restoration are different endpoints

Slide 46 · Luminal caliber explains the clinical cost

Uninjured wall

Neointimal expansion

Baseline artery: Relatively wide open lumen

Neointimal expansion: Smaller schematic lumen

Less luminal space may constrain downstream flow

Slide 47 · The lesion develops through a causal sequence

Trigger: EC injury

Response: SMC phenotypic shift

Tissue: Neointimal growth

Outcome: Stenosis

A diagnosis should distinguish the initiating disorder from this shared wall response.

Conceptual sequence — schematic

Slide 48 · Functional vasoconstriction differs from fixed tissue growth

Dynamic caliber change

Driven by contraction of vascular SMCs

Can occur without new intimal tissue

Reflects vascular tone

Structural intimal narrowing

Caused by added cells and matrix

Involves anatomical remodeling

Does not require persistent contraction

Slide 49 · Atherosclerotic plaques include intimal remodeling

Neointimal thickening is a core element in atherosclerotic plaque formation.

Plaque biology is broader than smooth muscle and matrix alone.

Recognizing the shared repair component does not make all neointima atherosclerosis.

Avoid treating “intimal thickening” and “atheromatous plaque” as synonyms.

Slide 50 · Stenting can be followed by intimal stenosis

Vascular intervention / wall injury

Neointimal repair response

Accumulation of SMCs and ECM

Potential in-stent narrowing

The principle is repair-associated luminal encroachment; No incidence or treatment claim is implied.

Conceptual sequence — schematic

Slide 51 · Surgical grafts can undergo similar remodeling

Surgical graft-associated vessel injury

Endothelial and SMC responses

Neointimal tissue formation

Possible graft-associated stenosis

The vessel wall uses a similar repair repertoire after different insults.

Conceptual sequence — schematic

Slide 52 · Vasculitis can also culminate in intimal narrowing

Vascular inflammation

EC dysfunction and mediator exposure

SMC / matrix response

Potential stenosis

Inflammation identifies the context; Neointimal expansion describes the response.

Conceptual sequence — schematic

Slide 53 · Transplant vasculopathy shares the endpoint

Solid-organ transplantation

Vasculopathic wall injury

Intimal SMC and matrix accumulation

Flow-limiting luminal narrowing

This shared mechanism without specifying transplant subtype or treatment.

Conceptual sequence — schematic

Slide 54 · One repair program, different clinical settings

Mechanism of thickening is shared; Initiating pathology differs.

Atherosclerotic lesion

Neointimal component within a more complex plaque

After stenting

Repair-associated intimal stenosis

After vascular grafting

Graft-associated intimal thickening

Vasculitis

Inflammation-associated intimal response

Solid-organ rejection

Transplant-associated vasculopathy

Slide 55 · What is being described: Process or diagnosis?

Histopathologic process

SMC recruitment and expansion

Matrix deposition in intimal layer

Potential stenosis

Etiologic context

Device or graft-associated injury

Inflammatory vascular disease

Atherosclerosis or transplant vasculopathy

Slide 56 · What should a schematic vessel section show?

The neointima occupies the inner wall compartment.

SMCs and ECM coexist in this newly formed tissue.

The lumen is narrower when the tissue encroaches inward.

Schematic geometry is illustrative, not a measured cross-section or a substitute for histology.

Slide 57 · Morphology has a source-availability limitation

The supplied excerpt does not provide an authentic neointimal photomicrograph.

The lecture therefore uses explicitly labeled native vector schematics.

No unverified stain pattern, cellular count or diagnostic cutoff is inferred.

A real histologic section is needed for evidence-based microscopic recognition.

Slide 58 · Case reasoning: Narrowing after stent placement

Clinical context

A previously treated artery later develops a narrowed lumen at the intervention site.

Which common wall-repair mechanism can account for this?

Mechanistic interpretation

Vessel injury prompts SMC recruitment and phenotypic switching.

Proliferating SMCs and synthesized ECM expand the intima.

Neointimal growth can narrow the lumen.

Slide 59 · Case reasoning: An inflamed arterial wall

Clinical context

A vessel affected by vasculitis becomes stenotic as the wall response evolves.

How can inflammation translate into structural narrowing?

Mechanistic interpretation

Inflammation can cause EC dysfunction and mediator release.

SMCs enter the intima, proliferate and produce matrix.

Neointimal tissue formation can reduce the lumen.

Slide 60 · Case reasoning: A transplanted organ

Clinical context

A graft develops a vasculopathic arterial lesion with progressive intimal expansion.

Why is this part of the same injury-response family?

Mechanistic interpretation

Solid-organ rejection-associated vasculopathy is cited as a setting.

The shared mechanism is SMC and ECM accumulation in the intima.

The clinical consequence can be impaired graft vessel flow.

Slide 61 · Case reasoning: The endothelium has healed

Clinical context

The luminal endothelial lining is restored after injury, but the vessel remains narrowed.

Does the repair endpoint imply the lumen is normal?

Mechanistic interpretation

No: EC coverage and intimal tissue mass are separate outcomes.

Neointimal SMC proliferation may subside after EC normalization.

Preexisting SMC and matrix accumulation may persist.

Slide 62 · Case reasoning: Identify the dominant cell program

Clinical context

SMCs in an injured vessel show increased cell division and matrix synthesis with less contractile activity.

Which phenotype is being described?

Mechanistic interpretation

The injury-associated proliferative, biosynthetic SMC phenotype.

It contrasts with a predominantly contractile, nonproliferative medial state.

This switch is central to neointimal formation.

Slide 63 · Integrative mechanism map

Injury → EC dysfunction / loss

SMC recruitment + phenotype switch

SMC proliferation + ECM deposition

Neointimal growth → possible stenosis

A common vascular response can be useful for repair and harmful for perfusion.

Conceptual sequence — schematic

Slide 64 · Consolidated concepts to retain

Cell of primary response

Smooth muscle cell (from media or circulating precursors)

Compartment of new tissue

Intimal layer

Second structural component

Extracellular matrix

Dominant upstream event

Endothelial dysfunction or loss

Possible later cellular state

Reduced proliferation after endothelial normalization

Clinical consequence

Luminal narrowing across diverse vascular diseases

Slide 65 · Primary source

Robbins, Cotran & Kumar: Pathologic Basis of Disease. 11th edition. Elsevier; 2026.

Primary reading: vascular wall response to injury, endothelial cells, and vascular smooth muscle cells.

Teaching schematics in this deck are original editable PowerPoint drawings, not histologic specimens.

Privacy preferences

Essential storage remembers your theme and privacy choice. Secure forms and teaching requests remain available whichever option you choose.

Teaching activity uses separate aggregate counters and short-lived sessions. SlideShare links open the original presentations on SlideShare. Form security checks are provided by third parties.

No message text, email addresses, visitor identifiers, or destination URLs are included in optional measurement. Read privacy details